Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients.
Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Watanabe Y, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; JET Study Group. Akizawa T, et al. Among authors: bessho m. Ther Apher Dial. 2014 Oct;18(5):404-13. doi: 10.1111/1744-9987.12155. Epub 2014 Feb 25. Ther Apher Dial. 2014. PMID: 24571446
Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study).
Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Watanabe Y, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; Co-JET Study Group. Akizawa T, et al. Among authors: bessho m. Ther Apher Dial. 2014 Apr;18(2):140-8. doi: 10.1111/1744-9987.12066. Epub 2013 Aug 27. Ther Apher Dial. 2014. PMID: 24720404
Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study.
Watanabe Y, Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; Co-JET Study Group. Watanabe Y, et al. Among authors: bessho m. Ther Apher Dial. 2016 Dec;20(6):598-607. doi: 10.1111/1744-9987.12425. Epub 2016 Dec 7. Ther Apher Dial. 2016. PMID: 27928910
Diagnostic significance of serum soluble transferrin receptors in various anemic diseases: the first multi-institutional joint study in Japan.
Matsuda A, Bessho M, Mori S, Takeuchi T, Abe T, Yawata Y, Mori H, Omine M, Nakamura Y, Furusawa S, Maeda T, Haginosita S, Hirasawa Y, Kinugasa E, Akizawa T, Kawakami N, Nagata A, Hirashima K. Matsuda A, et al. Among authors: bessho m. Haematologia (Budap). 2002;32(3):225-38. doi: 10.1163/15685590260461048. Haematologia (Budap). 2002. PMID: 12611483
Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.
Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R. Morishima Y, et al. Among authors: bessho m. Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074. Int J Hematol. 2004. PMID: 15540902 Clinical Trial.
Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group.
Bessho M, Hirashima K, Asano S, Ikeda Y, Ogawa N, Tomonaga M, Toyama K, Nakahata T, Nomura T, Mizoguchi H, Yoshida Y, Niitsu Y, Kohgo Y. Bessho M, et al. Eur J Haematol. 1997 Apr;58(4):265-72. doi: 10.1111/j.1600-0609.1997.tb01665.x. Eur J Haematol. 1997. PMID: 9186538 Clinical Trial.
223 results